Arch Biopartners Inc. (ARCH)

Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH

Q: Good day gurus,

I took the plunge on Arch a couple of months ago.

So far so good.

What do you think about its prospects/future trend?

Regards,
Dave

Read Answer Asked by DAVE on December 18, 2021

Profound Medical Corp. (PRN $8.10)
- $8.10 Cap: $239M
- View PRN Profile
- View Questions on PRN
Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH
Medicenna Therapeutics Corp. (MDNA $0.84)
- $0.84 Cap: $70M
- View MDNA Profile
- View Questions on MDNA

Q: What are your top three picks in the Canadian Biotechnolgy sector, and what do you like about them.
Thanks!

Read Answer Asked by Chuck on October 07, 2021

Arch Biopartners Inc. (ARCH $1.69)
- $1.69 Cap: $114M
- View ARCH Profile
- View Questions on ARCH

Q: Could I get your opinion on Arch Biopartners and whether or not it would be a buy, hold or sell (for a 2-4year outlook). Symbol is ACH on the TSX Venture Exchange. Thank you.

Read Answer Asked by Toge on September 11, 2017